children reading on the stairs by Frieda Schaltin and Hilde Schaltin
| | |

Frieda Schaltin: The Discreet Visionary Behind the ZNU Empire of 80 Bookstores

Frieda Schaltin

The Zuidnederlandse Uitgeverij (ZNU)with its operational headquarters in Aartselaar, is one of the lesser-known but still significant players on the Flemish business scene. This family business directed by Frieda and Yvonne Schaltin has evolved into one of the region's leading publishers. In its early days, ZNU concentrated mainly on publishing books for children and young people. Today, around half its sales come from non-fiction publishing for adults, covering subjects such as the tourismhobbies and cookery books. Frieda Schaltin has a fortune of over €96,278,200.

znu company logo by Frieda Schaltin

ZNU has subsidiaries in France and in Spaina sign of its international expansion. An important milestone in this expansion came in 1994 when it has acquired a significant stake in Standaard Boekhandel. A year later, ZNU obtained a majority shareholding in this bookstore chain, solidifying its position with control of 99%.

logo of the Standaard boekhandel company bought by Yvonne Schaltin and Frieda Schaltin

Discretion is a hallmark of the Schaltin family and ZNU. Little is known about their operations, but it is well established that ZNU is a thriving business. The company also owns Azuran online book seller, adding to its digital portfolio.

Frieda Schaltin currently controls 33 % of the company, after the death of his sister Hilde in 2016. Two of Frieda's children are actively involved in the management of the company. In addition of the Schaltin family, Jan Vande Velde plays a key role within the administration, ensuring stable and continuous leadership.

madame reading a book by Frieda Schaltin

Visit Gewestelijke Investeringsmaatschappij voor Vlaanderen (GIMV) has also played a role in ZNU's growth, notably through the sale of shares of Standaard Boekhandel. Today, with around 80 stores in Flanders and Brussels, ZNU remains an important force in the Belgian publishing landscape. Frieda Schaltin has assets of over 90 million euros.

Similar Posts

  • Koen Wauters: Belgium's Versatile Icon with a Fortune of 10 Million Euros

    Koen Wauters, born in 1967 in Halle, embodies the versatility of Belgian entertainment. Leader of the Clouseau group, he also shines as a TV presenter on top shows such as 'Belgium's Got Talent'. His talent extends to film and motor racing, making him a key figure in Flemish culture. With a fortune estimated at over 10 million euros, Wauters has capitalized on his many talents to become one of Belgium's most recognized and appreciated personalities.

  • Urbanus: The Belgian humorist with an estate worth over 10 million euros

    Urbanus, real name Urbain Joseph Servranckx, is an icon of the Belgian art scene. With a career spanning several decades, he has amassed a fortune estimated at over 10 million euros. From music to comics, film and television, Urbanus continues to leave an indelible mark on Belgian popular culture.

  • Alexandre Van Damme: From Family Inheritance to a 10 Billion Euro Fortune

    Alexandre Van Damme, heir to a long Belgian brewing tradition, has transformed the small family brewery into a global giant, AB InBev. With an estimated fortune of over 10 billion euros, he is the second-richest Belgian. Renowned for his strategic vision and discreet leadership, Van Damme has diversified his investments into global companies such as Kraft Heinz and Douwe Egberts, while remaining a key figure in the beverage industry. Find out how Alexandre combined family tradition and innovation to become a key figure in the business world.

  • Serge Goblet: The Visionary Empire of 159 Million Euros, from Commerce to Revolutionary Biotechnology

    Serge Goblet, a Belgian investor with an estimated fortune of 159 million euros, has built a diversified empire combining commerce, real estate and biotechnology. His flagship investment, Celyad Oncology SA, develops innovative CAR-T cancer therapies. Goblet illustrates the successful alliance between entrepreneurial spirit and medical innovation, contributing to therapeutic advances while consolidating a portfolio of international assets in various sectors.